Main issue is anemic growth on a quarterly basis ARR of $3.4m vs $3.3m on Q4 FY21 and cash receipts of $3.8m vs $3.94m. Hopefully this is a seasonal issue, but on this trajectory they will run out of cash before they grow into break even position.
Main issue is anemic growth on a quarterly basis ARR of $3.4m vs...
Add RMY (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.0¢ |
Change
-0.002(2.17%) |
Mkt cap ! $50.21M | |||
| Open | High | Low | Value | Volume |
| 8.8¢ | 9.0¢ | 8.5¢ | $16.38K | 190.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 139700 | 8.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.1¢ | 48736 | 1 |
View Market Depth
| Last trade - 15.51pm 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
9.0¢ |
Change
-0.002 ( 1.10 %) |
||||
| Open | High | Low | Volume | ||
| 8.6¢ | 9.0¢ | 8.5¢ | 78638 | ||
| Last updated 15.51pm 05/06/2024 ? | |||||
| RMY (ASX) Chart |